Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Open House Drug Discount Agreements For The Active Ingredient Aflibercept, With A Potency Of 40 Mg/ml, Atc S01la05 2026-05-16
Germany Open House Drug Discount Agreements For The Active Ingredient Apremilast, Atc L04aa32 2026-05-16
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Lebrikizumab, Atc D11ah10 For The Period January 1st, 2026 - December 31st, 2027 2026-05-16
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Paliperidone (exclusively 3-month Depot), Atc N05ax13 For The Period January 1st, 2026 - December 31st, 2027 2026-05-16
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Dimethyl Fumarate, Atc D05bx02 For The Period January 1st, 2026 - December 31st, 2027 2026-05-16
Germany Open House Drug Discount Agreements For The Active Ingredient Aflibercept, With A Potency Of 40 Mg/ml, Atc S01la05 2026-05-16
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Paliperidone (exclusively 3-month Depot), Atc N05ax13 For The Period January 1st, 2026 - December 31st, 2027 2026-05-16
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Dimethyl Fumarate, Atc D05bx02 For The Period January 1st, 2026 - December 31st, 2027 2026-05-16
Germany Disposal Of Blood Irradiation Devices 2026-05-16
Germany Intent To Conclude A Contract For The Supply Of Aids (here: Pg 17 - Devices For Compression Therapy) Including The Related Services According To § 127 Paragraph 1 Sgb V 2026-05-16
Whats app